SS
PRTC

SBI Securities’s PureTech Health PRTC Stock Holding History

SBI Securities’s Portfolio PRTC Stock Details PRTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$37 – 4177
2025
Q3 		$37 Buy
+2
New +$35 ﹤0.01% 3794

Other funds holding PRTC

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities's PRTC Position: Q4 2025 in Review

SBI Securities sold out of PureTech Health (PRTC) in Q4 2025, closing a stake of 2 shares — an estimated $37 sold.

SBI Securities first reported a position in PRTC in Q3 2025 and held it in 1 quarter. The position peaked at $37 in Q3 2025. 5 funds tracked by Wall St. Rank hold PRTC as of Q4 2025.

  • SBI Securities reported no remaining PureTech Health position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 2 PureTech Health shares in Q4 2025, an estimated $37.
  • SBI Securities first reported a position in PureTech Health in Q3 2025 and held it in 1 quarter.
  • SBI Securities's PureTech Health position peaked at $37 in Q3 2025.
  • 5 funds tracked by Wall St. Rank held PureTech Health as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.